Skip to content
Clinical Trials – home

Koenig-Ludwig-Haus Orthopaedische Klinik

Research site

Germany Brettreichstrasse 11, Frauenland, 97074 Wuerzburg, Germany

  • 4 trials recruiting
  • Osteoarthritis
  • Adult patients

About Specializations

Koenig-Ludwig-Haus Orthopaedische Klinik in Wuerzburg, Germany specialises in clinical trials of conditions such as Osteoarthritis, and other specialisations. This site conducts important research.

Main research areas of the site

Orthopedic Research and Innovations

The medical center is at the forefront of orthopedic research, focusing on pioneering treatments for patellofemoral osteoarthritis. This condition, affecting the cartilage behind the kneecap, is being addressed through advanced tissue engineering techniques.

  • Tissue Engineered Nasal Cartilage
  • Innovative Cartilage Repair
  • Randomized Controlled Trials

By utilizing tissue engineered nasal cartilage, the center aims to provide a novel therapeutic approach that could significantly improve patient outcomes. The ongoing research is designed to assess the efficacy of this treatment in reducing pain and enhancing joint function over a 24-month period.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Brettreichstrasse 11, Frauenland97074 WuerzburgGermany
Recruiting now
4 trials
Conditions studied
1

More sites in WuerzburgGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Osteoarthritis

Recruiting

A Study of Orforglipron for Knee Pain Relief in Adults with Obesity or Overweight and Knee Osteoarthritis

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Orforglipron hemicalcium
  • Sponsor:Eli Lilly & Co.

Osteoarthritis

Recruiting

Study on Treating Knee Osteoarthritis with Nasal Cartilage Implantation for Patients with Patellofemoral Osteoarthritis

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:N-Tec
  • Sponsor:Universitaetsspital Basel

Osteoarthritis

Recruiting

Study on Shortened Anticoagulation with Rivaroxaban for Blood Clot Prevention in Patients Undergoing Hip Replacement Surgery

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rivaroxaban
  • Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR

Osteoarthritis

Recruiting

Study on Treating Knee Osteoarthritis with N-TEC Implant for Patients with Patellofemoral Osteoarthritis

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:N-Tec
  • Sponsor:Universitaetsspital Basel
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.